New research study to see how the new weekly medicine IcoSema, controls blood sugar level in people with Type 2 Diabetes compared to insulin glargine taken daily.

Please fill in your details

Please enter first name.

Please enter last name.

Please enter valid email.

Please enter valid contact number.

Please select type of diabetes.

I confirm to have read the eligibilty criteria and qualify for this study

About the Study

This study to see how the new medicine IcoSema controls blood sugar levels in people with Type 2 diabetes. IcoSema is a combination of insulin icodec and semaglutide taken in a single injection once a week. When you have type 2 diabetes your blood sugar level is not well controlled, and insulin treatment can be helpful.

If you qualify, you may receive study-related care and study medication or an approved medication at no charge. You may also receive compensation for travel expenses.

Participant Eligibility Criteria ( To take part in the study )

Type 2 Diabetes & Above 18+ Years
Treated with daily long acting insulin
A1C is 7%-10%
BMI less than 40
Not currently using a CGM ( Continuous Glucose Monitoring )